Nancy Berliner
Affiliations: | Harvard Medical School, Boston, MA, United States |
Google:
"Nancy Berliner"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Thomé CH, Ferreira GA, Pereira-Martins DA, et al. (2020) NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia. Scientific Reports. 10: 10315 |
| Miller PG, Niroula A, Ceremsak JJ, et al. (2020) Identification of germline variants in adults with hemophagocytic lymphohistiocytosis. Blood Advances. 4: 925-929 |
| Nikiforow S, Berliner N. (2019) To "lump" or to "split" in Macrophage Activation Syndrome and Hemophagocytic Lymphohistiocytosis. Arthritis & Rheumatology (Hoboken, N.J.) |
| Lucena-Araujo AR, Coelho-Silva JL, Pereira-Martins DA, et al. (2019) Combining gene mutation with gene expression analysis improves outcomes prediction in acute promyelocytic leukemia. Blood |
| La Rosée P, Horne A, Hines M, et al. (2019) Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood |
| Nikiforow S, Berliner N, Kim HT, et al. (2019) Genetic Predispositions, Management Strategies, and Clinical Outcomes in Adults with Hemophagocytic Lymphohistiocytosis (HLH) after Reduced-Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplantation (HSCT) at Dana-Farber Cancer Institute Biology of Blood and Marrow Transplantation. 25 |
| Gansner JM, Berliner N. (2018) The rheumatology/hematology interface: CAPS and MAS diagnosis and management. Hematology. American Society of Hematology. Education Program. 2018: 313-317 |
| Pereira-Martins DA, Ortiz C, Franca-Neto PL, et al. (2018) Metformintreatment Overcomes ATRA-Resistance in Acute Promyelocytic Leukemia and Increases FOXO3A Expression Blood. 132: 1532-1532 |
| Lucena-Araujo AR, Pereira-Martins DA, Koury LC, et al. (2017) Clinical impact of BAALC expression in high-risk acute promyelocytic leukemia. Blood Advances. 1: 1807-1814 |
| Silva FBd, Figueiredo-Pontes LLd, Madeira MIA, et al. (2017) The application of an integrated clinical, cytogenetic, and molecular risk stratification for acute myeloid leukemia patients using a central laboratory in a Brazilian multicentric study Blood Advances. 1: 86-89 |